Interesting article on Achaogen and their antibiotic. There has been a lot of criticism of IPIX for not pursuing B-ABSSSI when PIII was discussed with FDA, but based upon this article, it appears it was a wise move to pursue B-OM and B-UP....I suspect we will know for sure very soon.

https://endpts.com/achaogens-bankruptcy-and-g...velopment/